|
Studied parameter
|
Lp-PLA2 (ng/ml)
|
|---|
|
Pre-treatment correlations
|
Post-treatment correlations
|
|---|
|
r
|
p
|
R
|
p
|
|---|
|
Age
|
0.350
|
0.001
|
0.409
|
<0.001
|
|
BMI (kg/m2)
|
0.331
|
0.001
|
0.258
|
0.014
|
|
FBG (mg/dl)
|
0.353
|
0.001
|
0.412
|
<0.001
|
|
HbA1c
|
0.332
|
0.001
|
0.403
|
<0.001
|
|
Platelets (103/훍l)
|
−0.225
|
0.033
|
−0.229
|
0.03
|
|
AST (IU/l)
|
0.188
|
0.076
|
0.296
|
0.005
|
|
ALT (IU/l)
|
0.099
|
0.355
|
0.033
|
0.76
|
|
Albumin (g/dl)
|
−0.336
|
0.001
|
−0.31
|
0.003
|
|
LDL (mg/dl)
|
0.142
|
0.182
|
0.197
|
0.062
|
|
Total cholesterol (mg/dl)
|
0.077
|
0.468
|
0.043
|
0.689
|
|
HDL (mg/dl)
|
−0.096
|
0.366
|
−0.284
|
0.007
|
|
Framingham score
|
0.669
|
<0.001
|
0.677
|
<0.001
|
|
Liver stiffness score (kPa)
|
0.157
|
0.139
|
0.276
|
0.008
|
- Abbreviations: Lp-PLA2, lipoprotein-associated phospholipase A2; BMI, body mass index; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; AST, aspartate transaminase; ALT, alanine transaminase; LDL, low-density lipoprotein; HDL, high-density lipoprotein
